Locus Pharmaceuticals is a pioneering biotechnology company specializing in drug discovery and development. Established in 1998, the company leverages its patented drug design technology to create innovative therapeutics. It has formed strategic collaborations with pharmaceutical partners and developed a promising pipeline of early-stage drug candidates targeting cancer and inflammatory conditions. In 08 July 2010, Locus Pharmaceuticals secured a significant $1.68M debt financing investment. Having demonstrated its commitment to advancing breakthrough treatments, the company presents a compelling opportunity for venture capital investment in the biotechnology and pharmaceutical sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Debt Financing | $1.68M | - | 08 Jul 2010 | |
| Series E | $30.20M | 3 |
|
14 Feb 2007 |
| Series E | $25.00M | - | 13 Nov 2006 | |
| Series C | $40.00M | 6 |
|
07 Nov 2001 |
| Series B | $42.75M | 1 |
|
28 Nov 2000 |
No recent news or press coverage available for Locus Pharmaceuticals.
-logo.jpg){kind=logo}
We care about your data, and we'd love to use cookies make your experience better.